Feb. 10, 2007
Audio Journal of Cardiovascular Medicine GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension REFERENCE: Abstract No. LB2 CHRISTOPHER GRAY, University of Newcastle Treating high blood sugar in the acute phases of stroke doesn’t reduce risk of death or severe disability, the GIST – UK (Glucose Insulin in Stroke Trial) has found. This is despite other trials reporting that high glucose levels are associated with increase risk of stroke. Investigators also found that treating glucose levels aggressively also lowered blood pressure. To discuss this surprise result, and the background to the trial, Helen Morant talked to Chris Gray.
